http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2481602-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581265968346f63692c94fc23fc6bae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42eeb8b1707e0ca53ff8062568e106b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85a482ddca1e71e472aaf88f44c7caf1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254947f2ae198ae8256b61ef74f0c7fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a5f07d5474df7d6fdcc2ccd67b53ae
publicationDate 2003-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2481602-A1
titleOfInvention Pharmaceutical composition comprising arsenite for the treatment of malignancy
abstract The invention relates to a pharmaceutical composition for the treatment of a solid malignancy chosen from the group consisting of colon tumour, gastric tumour, mammary tumour, ovarian tumour, prostate tumour, and renal tumour, said composition comprising a salt of meta-arsenite (AsO2-) and a pharmaceutically acceptable auxiliary. The invention also relates to its use and to a method of treatment.
priorityDate 2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID544

Total number of triples: 24.